Cardan Capital Partners’s Medtronic MDT Stock Holding History

Cardan Capital Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.09M	Buy	8,693 +987	+13%	+$128K	0.12%	123
2021 Q2	$957K	Buy	7,706 +161	+2%	+$20.2K	0.11%	134
2021 Q1	$891K	Buy	7,545 +454	+6%	+$53.2K	0.11%	129
2020 Q4	$831K	Buy	7,091 +712	+11%	+$78.4K	0.1%	119
2020 Q3	$663K	Hold	6,379	–	–	0.09%	136
2020 Q2	$585K	Hold	6,379	–	–	0.08%	133
2020 Q1	$575K	Sell	6,379 -272	-4%	-$28.9K	0.1%	121
2019 Q4	$755K	Buy	6,651 +63	+1%	+$6.91K	0.1%	117
2019 Q3	$716K	Hold	6,588	–	–	0.1%	124
2019 Q2	$642K	Sell	6,588 -302	-4%	-$27.6K	0.1%	120
2019 Q1	$628K	Hold	6,890	–	–	0.1%	116
2018 Q4	$627K	Buy	6,890 +155	+2%	+$14.5K	0.11%	105
2018 Q3	$663K	Hold	6,735	–	–	0.1%	100
2018 Q2	$577K	Sell	6,735 -1,591	-19%	-$133K	0.09%	103
2018 Q1	$668K	Buy	+8,326	New	+$687K	0.11%	99

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.14B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cardan Capital Partners's MDT Position: Q3 2021 in Review

Cardan Capital Partners increased its Medtronic (MDT) stake by 13% in Q3 2021, buying an estimated $128K and bringing the position to 8,693 shares worth $1.09M. The position accounts for 0.12% of the portfolio, ranked #123.

Cardan Capital Partners first reported a position in MDT in Q1 2018 and has held it in 15 quarters since. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

Cardan Capital Partners held 8,693 shares of Medtronic worth $1.09M as of Q3 2021.
Cardan Capital Partners bought 987 Medtronic shares in Q3 2021, an estimated $128K.
Medtronic made up 0.12% of Cardan Capital Partners's portfolio in Q3 2021, its #123 holding.
Cardan Capital Partners first reported a position in Medtronic in Q1 2018 and has held it in 15 quarters since.
2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Cardan Capital Partners's 13F filing for Q3 2021, filed 25 Oct 2021.